Class 3 Medicines Recall: Glenmark Pharmaceuticals Europe Ltd
Class 3 Medicines Recall: Glenmark Pharmaceuticals Europe Ltd Cyanocobalamin 50 mcg Tablets, EL(24)A/46
Glenmark Pharmaceuticals Europe Ltd is recalling the affected batches as a precautionary measure due to out of specification results for unknown impurities during routine stability testing and additional re-testing.
DMRC Number: DMRC-31522269
Company name: Glenmark Pharmaceuticals Europe Ltd
Product description: Cyanocobalamin 50 mcg Tablets, PL 25258/0369
SNOMED Code: N/A
Details of the affected batch:
| Batch No | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 17231378A | 30-Nov-2024 | 50 | 01-Oct-2023 |
| 17231510A | 30-Nov-2024 | 50 | 14-Mar-2024 |
| 17231511A | 31-Dec-2024 | 50 | 17-Apr-2024 |
Active Pharmaceutical Ingredient: cyanocobalamin
Brief description of problem:
Glenmark Pharmaceuticals Europe Ltd is recalling the affected batches as a precautionary measure due to out of specification results for unknown impurities during routine stability testing and additional re-testing.
Advice to Healthcare Professionals:
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Advice to Patients:
No action is required by patients as this is a Pharmacy and Wholesaler level recall. Patients should continue to take medicines from these batches as prescribed by your healthcare professional.
Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Company contacts for further information:
For medical information enquiries please use the following options by phone +44 8004 580 383 or email medical_information@glenmarkpharma.com.
For stock control enquiries please email orders.uk@glenmarkpharma.com
To access the full recall: